Re-irradiation plus pembrolizumab: Phase II study for recurrent glioblastoma patients
{{output}}
Purpose: Radiation therapy may enhance anti-tumor immune responses by several mechanisms including induction of immunogenic cell death. We performed a phase 2 study of pembrolizumab with re-irradiation in patients with recurrent ... ...
